INFECTION JOURNAL HEADLINE
INFECTION JOURNAL HEADLINE
販売サイト「MeReBo」へ
- 掲載誌
- up－to－date 子どもの感染症 Vol.12 No.1 44-45, 2024
- 著者名
- 岩田 敏 / 尾内 一信 / 岡田 賢司 / 細矢 光亮 / 石和田 稔彦 / 舘田 一博
- 記事体裁
- 抄録 / 連載
- 疾患領域
- 感染症 / 小児疾患
- 診療科目
- 小児科 / 感染症内科
- 媒体
- up－to－date 子どもの感染症
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003) : 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Tricou V, Yu D, Reynales H, et al. Lancet Glob Health. 2024；12：e257-70.
RSV Prefusion F Protein–Based Maternal Vaccine—Preterm Birth and Other Outcomes.
Dieussaert I, Hyung Kim J, Luik S, et al. N Engl J Med. 2024；390：1009-21.
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization.
Head JR, Collender PA, León TM, et al. JAMA Netw Open. 2024；7：e247822.
Epidemiological and clinical insights into the enterovirus D68 upsurge in Europe 2021–22 and the emergence of novel B3-derived lineages, ENPEN multicentre study.
Simoes MP, Hodcro EB, Simmonds P, et al. J Infect Dis. 2024；230：e917–28.
Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak.
Ramírez de Arellano E, Saavedra-Lozano J, Villalón P, et al. mSphere. 2024；9：e0072923.
The impact of EV71 vaccination program on hand, foot and mouth disease in Zhejiang Province, China: A negative control study.
Zheng D, Shen L, Wen W, et al. Infect Dis Model. 2023；8：1088-96.
※記事の内容は雑誌掲載時のものです。
